These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
331 related articles for article (PubMed ID: 3534703)
21. [Inhibition of the activity of urinary N-acetyl-beta-D-glucosaminidase (NAG) and its isoenzymes by amikacin]. Mozer JL; Gibey R; Henry JC C R Seances Soc Biol Fil; 1989; 183(2):166-73. PubMed ID: 2531024 [TBL] [Abstract][Full Text] [Related]
22. [Clinical evaluation of urinary n-acetyl-beta-d-glucosaminidase activity in patients treated with aminoglycosides]. Hirokawa N; Naruse T Nihon Jinzo Gakkai Shi; 1982 Sep; 24(9):1041-53. PubMed ID: 7161951 [No Abstract] [Full Text] [Related]
23. Early monitoring of human renal transplantations by N-acetyl-beta-D-glucosaminidase isoenzyme activities in urines. Bourbouze R; Gluckman JC; Frantz P; Paraire M; Baumann FC; Luciani J; Percheron F; Legrain M Clin Chim Acta; 1985 Jul; 149(2-3):185-95. PubMed ID: 3896578 [TBL] [Abstract][Full Text] [Related]
25. The effect of netilmicin and other aminoglycosides on renal function. A survey of the literature on the nephrotoxicity of netilmicin. Dahlager JI Scand J Infect Dis Suppl; 1980; Suppl 23():96-102. PubMed ID: 7010549 [TBL] [Abstract][Full Text] [Related]
26. Variation in the isoenzymes of N-acetyl-beta-D-glucosaminidase and protein excretion in aminoglycoside nephrotoxicity in the rat. Sanchez-Bernal C; Vlitos M; Cabezas JA; Price RG Cell Biochem Funct; 1991 Jul; 9(3):209-14. PubMed ID: 1752026 [TBL] [Abstract][Full Text] [Related]
27. Serum cystatin C level for better assessment of glomerular filtration rate in cystic fibrosis patients treated by amikacin. Halacova M; Kotaska K; Kukacka J; Vavrova V; Kuzelova M; Ticha J; Prusa R J Clin Pharm Ther; 2008 Aug; 33(4):409-17. PubMed ID: 18613859 [TBL] [Abstract][Full Text] [Related]
28. [Urinary enzyme determination and its clinical significance. C. Enzyme derived from the kidney tubular epithelium--N-acetyl-beta-D-glucosaminidase. 10. Clinical significance of urinary NAG activity in patients with kidney diseases, with special reference to nephrotic syndrome and antibiotic treatment]. Ishimoto F; Shibazaki T; Murai S; Kodama K; Ohno I; Gomi H Rinsho Byori; 1983 Sep; Spec No 56():147-59. PubMed ID: 6663756 [No Abstract] [Full Text] [Related]
29. [Comparison of urinary and seminal N-acetyl-beta-glucosaminidase isoenzymes]. Yasumoto R; Asakawa M; Yamamoto M; Doi Y; Kawashima H; Umeda M; Tanabe S; Nishisaka N; Kakinoki K; Maekawa M Hinyokika Kiyo; 1987 Nov; 33(11):1827-9. PubMed ID: 3445866 [TBL] [Abstract][Full Text] [Related]
30. The nephrotoxic potential of netilmicin as determined in a rat model. Luft FC Scand J Infect Dis Suppl; 1980; Suppl 23():82-90. PubMed ID: 6937971 [TBL] [Abstract][Full Text] [Related]
31. N-acetyl-beta-D-glucosaminidase (NAG) and NAG isoenzymes in children with upper and lower urinary tract infections. Viganò A; Assael BM; Dalla Villa A; Gagliardi L; Principi N; Ghezzi P; Salmona M Clin Chim Acta; 1983 Jun; 130(3):297-304. PubMed ID: 6872263 [TBL] [Abstract][Full Text] [Related]
32. Evaluation of urinary elimination of N-acetyl-beta-glucosaminidase in healthy volunteers treated with dibekacin or gentamicin. Camí J; Segura J; Baños JE; Garcia I; Drobnic L Antimicrob Agents Chemother; 1982 Jun; 21(6):1013-5. PubMed ID: 7114833 [TBL] [Abstract][Full Text] [Related]
33. Varied value of urinary N-acetyl-beta-D-glucosaminidase isoenzyme B in males of reproductive age. Itoh Y; Numata Y; Morita A; Asano Y; Kawai T Kidney Int Suppl; 1994 Nov; 47():S38-42. PubMed ID: 7869670 [TBL] [Abstract][Full Text] [Related]
34. [Functional, histological, biochemical renal modifications. Comparative study of dibekacin, gentamicin, tobramycin, netilmicin and amikacin]. Viotte G; Olier B; Morin JP; Godin M Nouv Presse Med; 1982 Nov; 11(46):3419-25. PubMed ID: 7155850 [TBL] [Abstract][Full Text] [Related]
35. Enzymuria as a marker of renal injury and disease: studies of N-acetyl-beta-glucosaminidase in the general population and in patients with renal disease. Kunin CM; Chesney RW; Craig WA; England AC; DeAngelis C Pediatrics; 1978 Nov; 62(5):751-60. PubMed ID: 364392 [TBL] [Abstract][Full Text] [Related]
36. Validity of N-acetyl-beta-D-glucosaminidase (NAG) determination in assessing netilmicin nephrotoxicity in preterm babies. Langhendries JP; Mattot M; François A; Deprez D; Battisti O; Bertrand JM; Schoos S Biol Neonate; 1989; 56(2):76-82. PubMed ID: 2790088 [TBL] [Abstract][Full Text] [Related]
37. The excretion of N-acetyl-beta-glucosaminidase in glomerulonephritis. Hultberg B; Ravnskov U Clin Nephrol; 1981 Jan; 15(1):33-8. PubMed ID: 7214750 [TBL] [Abstract][Full Text] [Related]
38. [Determination of urinary N-acetyl-beta-D-glucosaminidase (NAG) excretion as a parameter of nephrotoxicity due to cis-platin and the effect of fosfomycin (FOM) on its nephrotoxicity]. Matsuoka R; Inoue T; Miyamura K; Mizutani K; Koike S; Mori H; Kigawa T Nihon Sanka Fujinka Gakkai Zasshi; 1986 Nov; 38(11):2037-44. PubMed ID: 3794453 [TBL] [Abstract][Full Text] [Related]
39. Urinary excretion of N-acetyl-glucosaminidase and beta-2-microglobulin as early markers of gentamicin nephrotoxicity in neonates. Gouyon JB; Aujard Y; Abisror A; Laudignon N; d'Athis P; Jacqz E; Biou D; Demelier JF; Mathieu H Dev Pharmacol Ther; 1987; 10(2):145-52. PubMed ID: 3301233 [TBL] [Abstract][Full Text] [Related]
40. [Urinary N-acetyl-beta-glucosaminidase as index of renal toxicity (author's transl)]. Oudart N; Marcher K; Lacour B; Boulu RG; Guichard C Toxicol Eur Res; 1981 May; 3(3):149-51. PubMed ID: 7281165 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]